Crossmark

Experience with new anti-CD20 monoclonal antibodies for immune-mediated glomerulopathies in a tertiary hospital

Crossref DOI link: https://doi.org/10.1016/j.nefroe.2025.501372

Published Print: 2025-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Iván Zamora, Jorge

López-Martínez, Marina

Ramos, Natalia

Bermejo, Sheila

Agraz, Irene

García-Carro, Clara

Patricio, Marc

León, Juan Carlos

Toapanta, Néstor

Bestard, Oriol

Soler, María José https://orcid.org/0000-0003-3621-0766
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (RICORS RD21/0005/0016)

Instituto de Salud Carlos III (JTC2022)

Instituto de Salud Carlos III (CM23/00213)

Instituto de Salud Carlos III (AC22/00029)

Instituto de Salud Carlos III (RD24/0004/0031)

Instituto de Salud Carlos III (PI24/01510)

Instituto de Salud Carlos III (215/C/2021)

Instituto de Salud Carlos III (PI21/01292)

Instituto de Salud Carlos III (PI23/01209)
License Information

Text and Data Mining valid from 2025-12-01

Text and Data Mining valid from 2025-12-01

Version of Record valid from 2025-11-28
More Information

This article is maintained by: Elsevier

Article Title: Experience with new anti-CD20 monoclonal antibodies for immune-mediated glomerulopathies in a tertiary hospital

Journal Title: Nefrología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefroe.2025.501372

Content Type: article

Copyright: © 2025 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología.